Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmanostra is a prominent Brazilian distributor of pharmaceutical raw materials, specializing in the compounding pharmacy (magistral) sector. Established in 1982, the company provides a comprehensive portfolio of active pharmaceutical ingredients (APIs), excipients, and specialized formulations to healthcare providers across Brazil. In 2011, Pharmanostra was acquired by the Dutch multinational Fagron, a global leader in pharmaceutical compounding, to strengthen its presence in the Latin American market. The company is recognized for its rigorous quality control standards and its role in supporting personalized medicine through technical innovation and education for pharmacists. Pharmanostra continues to operate as a key brand within the Fagron Group, focusing on dermatology, nutrition, and hormone replacement therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmanostra.